International Clinical Trial: A Phase I, first-in-human study to assess safety, tolerability, and immunogenicity of the Rift Valley Fever virus Vaccine DDvax in healthy adult participants

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607634582899) titled 'A Phase I, first-in-human study to assess safety, tolerability, and immunogenicity of the Rift Valley Fever virus Vaccine DDvax in healthy adult participants' on July 28.

Study Type: Interventional

Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Allocation was determined by the holder of the sequence who is situated off site

Primary Sponsor: One Health Institute University of California Davis

Condition: Rift Valley Fever Rift Valley Fever

Intervention: DDv...